Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-GLucose coTransporter-2 Inhibitors”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Not applicableStudy completedNCT07269197
What this trial is testing

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Josip Juraj Strossmayer University of Osijek 67
Not applicableStudy completedNCT05344963
What this trial is testing

Deformation Imaging by Strain in Chronic Heart Failure Over Gliflozins: an Echocardiographic Register on Sodium-GLucose coTransporter-2 Inhibitors

Who this might be right for
Sodium-GLucose coTransporter-2 InhibitorsHeart Failure With Reduced Ejection Fraction
Matteo Cameli 503
Not applicableStudy completedNCT06964607
What this trial is testing

Impact of Sodium Glucose Co-transporter 2-Inhibitors on Clinical Outcome and Left Ventricular Function in Patients Presented by Acute Myocardial Infarction

Who this might be right for
Sodium-glucose Cotransporter 2InhibitorsClinical Outcome+2 more
Tanta University 80
Not applicableStudy completedNCT06903754
What this trial is testing

ISGLT2 in Patients Without DM With Acute MI

Who this might be right for
Acute Coronary SyndromesHeart Failure
Mohammed VI University Hospital 450
Not applicableNot Yet RecruitingNCT06739486
What this trial is testing

Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non Alcholic Fatty Liver DiseaseHepatic SteatosisHepatic Fibrosis+1 more
Assiut University 100
Not applicableLooking for participantsNCT07444203
What this trial is testing

Transformative Research in Diabetic Nephropathy 2.0

Who this might be right for
Diabetic NephropathiesKidney DiseasesRenal Insufficiency, Chronic+1 more
University of Pennsylvania 200
Very early researchLooking for participantsNCT06609356
What this trial is testing

Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes MellitusGlucokinase-Maturity Onset Diabetes of the Young (GCK-MODY)MODY2 Diabetes+1 more
Vanderbilt University Medical Center 27
Testing effectiveness (Phase 2)Study completedNCT06150924
What this trial is testing

Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria

Who this might be right for
Chronic Kidney Disease
Mineralys Therapeutics Inc. 60
Post-approval studies (Phase 4)Not Yet RecruitingNCT07351864
What this trial is testing

Finerenone Plus SGLT2 Inhibitors in Heart Failure

Who this might be right for
Heart Failure
Mansoura University 60
Not applicableUnknownNCT06344247
What this trial is testing

Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease

Who this might be right for
ObesityChronic Kidney Diseases
RenJi Hospital 48
Testing effectiveness (Phase 2)Looking for participantsNCT07018622
What this trial is testing

Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity

Who this might be right for
Solid TumorsCisplatin Nephrotoxicity
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 46
Large-scale testing (Phase 3)Active Not RecruitingNCT07214818
What this trial is testing

SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Mansoura University 75
Early research (Phase 1)Study completedNCT03852901
What this trial is testing

Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production

Who this might be right for
EmpaglifozinPhysiological Effects of DrugsHypoglycemic Agents+1 more
National Institute on Aging (NIA) 21
Post-approval studies (Phase 4)UnknownNCT05975528
What this trial is testing

Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Type 2 Diabetes

Who this might be right for
Diabetes MellitusCellular SenescenceSodium-Glucose Transporter 2 Inhibitors
Yonsei University 92
Post-approval studies (Phase 4)Not Yet RecruitingNCT07405216
What this trial is testing

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease (Mild to Moderate)AlbuminuriaAdolescent+1 more
Centenario Hospital Miguel Hidalgo 200
Not applicableStudy completedNCT05990296
What this trial is testing

Evaluating Strategies to Improve Guideline Directed Medical Therapy: The GDMT Research, Education & Assist Trial for Heart Failure Care

Who this might be right for
Heart FailureHeart Failure With Reduced Ejection Fraction
Geisinger Clinic 4,306
Very early researchUnknownNCT05512130
What this trial is testing

Sodium-Glucose Cotransporter-2 Inhibitors: A Potential Novel Treatment for Epilepsy

Who this might be right for
Epilepsy
Washington University School of Medicine 18
Not applicableUnknownNCT06251453
What this trial is testing

Impact of Sodium-glucose Cotransporter 2 Inhibitors on Post-operative Atrial Fibrillation in Cardiothoracic Surgery

Who this might be right for
Atrial Fibrillation
Hamad Medical Corporation 3,280
Not applicableLooking for participantsNCT05999773
What this trial is testing

SGLT-2 Inhibitors in the Treatment of Ascites

Who this might be right for
Ascites HepaticCirrhosis, LiverDiabete Type 2
University of Palermo 40
Post-approval studies (Phase 4)Looking for participantsNCT06782139
What this trial is testing

Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity

Who this might be right for
Obesity and Type 2 Diabetes
Korea University Anam Hospital 30
Load More Results